Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.
about
Triglycerides as vascular risk factors: new epidemiologic insightsTriglyceride-rich lipoproteins as a causal factor for cardiovascular diseaseHypertriglyceridemia and Cardiovascular Diseases: RevisitedTriacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophagesCeramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosisMolecular imaging in atherosclerosis.Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.Influence on Adiposity and Atherogenic Lipaemia of Fatty Meals and Snacks in Daily Life.Overnutrition and maternal obesity in sheep pregnancy alter the JNK-IRS-1 signaling cascades and cardiac function in the fetal heart.Role of heparanase on hepatic uptake of intestinal derived lipoprotein and fatty streak formation in mice.Lipoproteins: When size really matters.Insulin resistance and cardiovascular disease.Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementPPARdelta is a very low-density lipoprotein sensor in macrophagesVery low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglyceridesNon-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarctionThe relative atherogenicity of VLDL and LDL is dependent on the topographic site.The association of very-low-density lipoprotein with ankle-brachial index in peritoneal dialysis patients with controlled serum low-density lipoprotein cholesterol level.Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy.Oxidation of chylomicron remnant-like particles inhibits their uptake by THP-1 macrophages by apolipoprotein E-dependent processes.The impact of Roux-en-Y gastric bypass surgery on normal metabolism in a porcine modelRemnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.Postprandial Peaking and Plateauing of Triglycerides and VLDL in Patients with Underlying Cardiovascular Diseases Despite Treatment.The effect of consuming low- versus high-glycemic index meals after exercise on postprandial blood lipid response following a next-day high-fat meal.Triglyceride alters lysosomal cholesterol ester metabolism in cholesteryl ester-laden macrophage foam cells.Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.Very low density lipoproteins stimulate surfactant lipid synthesis in vitro.Suppression of nuclear factor-kappaB activity in macrophages by chylomicron remnants: modulation by the fatty acid composition of the particles.Regulating intestinal function to reduce atherogenic lipoproteins.Postprandial VLDL lipolysis products increase monocyte adhesion and lipid droplet formation via activation of ERK2 and NFκB.Acute hypertriglyceridemia induces platelet hyperactivity that is not attenuated by insulin in polycystic ovary syndrome.Acidification of the intimal fluid: the perfect storm for atherogenesisLapaquistat acetate, a squalene synthase inhibitor, changes macrophage/lipid-rich coronary plaques of hypercholesterolaemic rabbits into fibrous lesions.Per os colchicine administration in cholesterol fed rabbits: Triglycerides lowering effects without affecting atherosclerosis progress.Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions.Lysosomes, cholesterol and atherosclerosis.Elevated Levels of Very Low-density Lipoprotein Cholesterol Independently Associated with In-stent Restenosis in Diabetic Patients after Drug-eluting Stent ImplantationCytokine response to lipoprotein lipid loading in human monocyte-derived macrophages.New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent.
P2860
Q24618902-8A34AA5C-B0AB-43D8-A0F9-D15CBEC34F63Q26745946-6EC735A8-F954-41CB-A94E-E007DF189FF1Q26750954-C2A9F76B-8AAB-40C5-9842-3A613CAC43BEQ28365592-E3490EA5-64F4-4A9C-AF07-C377D09BFF8BQ28547365-BA794CF1-E0C6-401E-9191-E27D48320D9EQ30478541-9FF97408-F5E4-406F-AA78-912326620633Q33752256-E9C3A937-1168-4500-BE0C-D0F5F1CDA933Q33863703-FE7A5028-9615-4D2F-B941-DE7DBBC98187Q33868714-71BCB8A1-35BB-45C8-9E11-BBF36FA0904BQ33869288-EE0EF439-7368-45D7-B060-A1353C1F6062Q33947533-8E9025E9-6BFF-4306-9D65-388E95410CE1Q34011027-C58119D2-DEC1-48EE-A71C-6B9EF828660BQ34181381-3514CECD-9C2F-445F-9DEB-5BC29D12BCB7Q34330290-309EAC43-F438-4A84-AA7E-3685D5326B20Q34406987-CE24AE2B-CAF5-47B4-947E-33161BA7632FQ34480124-7433B19F-5179-4472-B035-300C5795D011Q34559938-C1BDD82B-7E4E-43B5-9C8F-204DC8183B7BQ35007909-9097895B-96F4-4E79-869F-22F3013D9E1BQ35056603-24062BD8-004A-46AD-BFCC-3BFDAC0D8134Q35749021-57522237-2320-4E9F-9596-C28F1FBFE791Q35869143-5339E8C3-661F-4138-AB95-51677754C29BQ36296633-41F292AE-A4EB-4AAA-B8D1-4DBDFFA40972Q36956660-A1C5B16B-2CA3-485E-B912-0EBB408DBD66Q36957420-498249F6-874E-4B3B-A1E9-DDB9184FA537Q37151027-3CC98F73-3BD4-44BF-BD87-B2AAB4B314F1Q37337461-1571BF28-9CED-4E2A-BCFA-0B59CAF0967BQ37359981-1366849C-1AAC-48BE-BF95-966E1944BC11Q37366070-4B205C7F-EBDA-4D20-8E0D-6F0752BB5E02Q37420145-258D76A2-5727-4C66-8149-DF79A1683D7CQ37435572-E4511B12-5C70-4573-87C5-22C3203228C7Q37575951-25A4C16B-EE61-4E98-B079-EF5BEDF5D4C4Q37648474-7C0C6DCC-D4DE-4FA7-9DD5-0C01C51E3A55Q38271332-1697B706-0DDC-483B-841C-8E412B9E54D2Q39873548-5C85C41A-3954-407D-8238-885FB6336D83Q41675413-590B38EC-1E83-4F96-B985-94AB1CE3312FQ41821528-CD38A529-B102-4F00-AECB-A76E73804694Q42122586-040E549E-06CF-41B8-88DE-DB5BB2D05B05Q42267353-FF195057-B219-407D-95C2-C72EF632E14BQ42415859-654D36FF-4BFD-4652-A1C7-D0C51C383830Q52584406-48A5D842-F332-4AA1-8F32-F5D2712BDB80
P2860
Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Triglyceride-rich lipoproteins ...... human atherosclerotic plaque.
@en
Triglyceride-rich lipoproteins ...... human atherosclerotic plaque.
@nl
type
label
Triglyceride-rich lipoproteins ...... human atherosclerotic plaque.
@en
Triglyceride-rich lipoproteins ...... human atherosclerotic plaque.
@nl
prefLabel
Triglyceride-rich lipoproteins ...... human atherosclerotic plaque.
@en
Triglyceride-rich lipoproteins ...... human atherosclerotic plaque.
@nl
P2093
P921
P1476
Triglyceride-rich lipoproteins ...... m human atherosclerotic plaque
@en
P2093
A H Chaumeton
J Tweedie-Hardman
R L Hamilton
S T Kunitake
P304
P356
10.1161/01.ATV.14.11.1767
P577
1994-11-01T00:00:00Z